Sankofa pediatric HIV disclosure intervention did not worsen depression scores in children living with HIV and their caregivers in Ghana

Christopher Radcliffe, Aba Sam, Quinn Matos, Sampson Antwi, Kofi Amissah, Amina Alhassan, Irene Pokuaa Ofori, Yunshan Xu, Yanhong Deng, Nancy R Reynolds, Elijah Paintsil, Sankofa Team, Christopher Radcliffe, Aba Sam, Quinn Matos, Sampson Antwi, Kofi Amissah, Amina Alhassan, Irene Pokuaa Ofori, Yunshan Xu, Yanhong Deng, Nancy R Reynolds, Elijah Paintsil, Sankofa Team

Abstract

Background: The 'Sankofa' pediatric HIV disclosure study (2013-2017) was an intervention that aimed to address the low prevalence of disclosure of HIV status in Ghana.

Methods: We conducted a cross-sectional study at the intervention site in Kumasi, Ghana, in 2019, (2 years after study closure) and administered the 21-item Beck Depression Inventory (BDI) and the 10-item Child Depression Inventory (CDI) to caregiver-child dyads who received the intervention.

Results: We enrolled 65% (N = 157) of the original dyads in the present study. Between Sankofa enrollment baseline and the present study, both children and caregivers had significant (p < 0.0001) mean reductions in CDI scores and BDI scores, respectively. CDI scores of the children were significantly correlated with BDI scores of the caregivers (r = 0.019, p = 0.019). No statistically significant associations between disclosure status and either CDI score or BDI score were found.

Conclusions: Our findings did not support caregivers' fears that disclosure leads to depression.

Trial registration: ClinicalTrials.gov Identifier: NCT01701635 (date of registration Oct 5, 2012).

Keywords: Depression; Disclosure intervention; Ghana; Pediatric HIV.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Depression symptoms in children by disclosure group over time. Disclosure groups represent children who did or did not complete the disclosure process at each time point. Child Depression Inventory (CDI) scores for weeks 48, 96, and 144 were collected during the Sankofa parent study. POST data point was collected during the current study and represents time between enrollment in the parent study and the current study, which varies for study participants (median 5.19 years; IQR 4.16–6.07 years). Effect of disclosure status on CDI scores was evaluated using repeated measures analysis with disclosure status entered as time varying covariate. Abbreviation: CDI, Child Depression Inventory
Fig. 2
Fig. 2
Depression symptoms in caregivers by disclosure group over time. Disclosure groups represent caregivers of children who did or did not complete the disclosure process at each time point. Beck Depression Inventory (BDI) scores for weeks 48, 96, and 144 were collected during the Sankofa parent study. POST data point was collected during the current study and represents time between enrollment in the parent study and the current study, which varies for study participants (median 5.19 years; IQR 4.16–6.07 years). Effect of disclosure status on BDI scores was evaluated using repeated measures analysis with disclosure status entered as time varying covariate. Abbreviation: BDI, Beck Depression Inventory

References

    1. Children, HIV, and AIDS: Global snapshot 2019. UNICEF. dren-hiv-aids-global-snapshot/ Published July 2019. Accessed 12 Apr, 2020.
    1. Davies MA, Gibb D, Turkova A. Survival of HIV-1 vertically infected children. Curr Opin HIV AIDS. 2016;11(5):455–464. doi: 10.1097/COH.0000000000000303.
    1. Global HIV & AIDS statistics – 2019 fact sheet. UNAIDS. fact-sheet. Accessed 12 Apr, 2020.
    1. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and Virologic failure: a meta-analysis. Medicine (Baltimore) 2016;95(15):e3361. doi: 10.1097/MD.0000000000003361.
    1. Goga AE, Singh Y, Singh M, Noveve N, Magasana V, Ramraj T, et al. Enhancing HIV treatment access and outcomes amongst HIV infected Children and adolescents in resource limited settings. Matern Child Health J. 2017;21(1):1–8. doi: 10.1007/s10995-016-2074-1.
    1. Intasan J, Bunupuradah T, Vonthanak S, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, et al. Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial. AIDS Patient Care STDs. 2014;28(6):296–302. doi: 10.1089/apc.2013.0276.
    1. Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. Glob Health Res Pol. 2019;4(32):019–0120–019–0124.
    1. Nichols J, Steinmetz A, Paintsil E. Impact of HIV-status disclosure on adherence to antiretroviral therapy among HIV-infected children in resource-limited settings: a systematic review. AIDS Behav. 2017;21(1):59–69. doi: 10.1007/s10461-016-1481-z.
    1. Umeokonkwo CD, Onoka CA, Agu PA, Ossai EN, Balogun MS, Ogbonnaya LU. Retention in care and adherence to HIV and AIDS treatment in Anambra state Nigeria. BMC Infect Dis. 2019;19(1):654. doi: 10.1186/s12879-019-4293-8.
    1. Beima-Sofie KM, Brandt L, Hamunime N, Shepard M, Uusiku J, John-Stewart GC, et al. Pediatric HIV disclosure intervention improves knowledge and clinical outcomes in HIV-infected Children in Namibia. J Acquir Immune Defic Syndr. 2017;75(1):18–26. doi: 10.1097/QAI.0000000000001290.
    1. World Health Organization . Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011.
    1. Doat AR, Negarandeh R, Hasanpour M. Disclosure of HIV Status to Children in Sub-Saharan Africa: A Systematic Review. Medicina (Kaunas). 2019;55(8). 10.3390/medicina55080433.
    1. Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS. The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDs. 2010;24(10):639–649. doi: 10.1089/apc.2010.0079.
    1. Reynolds NR, Ofori-Atta A, Lartey M, Renner L, Antwi S, Enimil A, et al. SANKOFA: a multisite collaboration on paediatric HIV disclosure in Ghana. AIDS. 2015;29(Suppl 1):S35–S45. doi: 10.1097/QAD.0000000000000725.
    1. Kallem S, Renner L, Ghebremichael M, Paintsil E. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011;15(6):1121–1127. doi: 10.1007/s10461-010-9741-9.
    1. Paintsil E, Renner L, Antwi S, Dame J, Enimil A, Ofori-Atta A, et al. HIV knowledge, stigma, and illness beliefs among pediatric caregivers in Ghana who have not disclosed their child's HIV status. AIDS Care. 2015;27(Suppl 1):18–27. doi: 10.1080/09540121.2015.1007116.
    1. O'Malley G, Beima-Sofie K, Feris L, Shepard-Perry M, Hamunime N, John-Stewart G, et al. "if I take my medicine, I will be strong: " evaluation of a pediatric HIV disclosure intervention in Namibia. J Acquir Immune Defic Syndr. 2015;68(1):e1–e7. doi: 10.1097/QAI.0000000000000387.
    1. Vreeman RC, Scanlon ML, Marete I, Mwangi A, Inui TS, McAteer CI, et al. Characteristics of HIV-infected adolescents enrolled in a disclosure intervention trial in western Kenya. AIDS Care. 2015;27(Suppl 1):6–17. doi: 10.1080/09540121.2015.1026307.
    1. Bronfenbrenner U, Ceci SJ. Nature-nurture reconceptualized in developmental perspective: a bioecological model. Psychol Rev. 1994;101(4):568–586. doi: 10.1037/0033-295X.101.4.568.
    1. Fisher JD, Fisher WA, Williams SS, Malloy TE. Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students. Health Psychol. 1994;13(3):238–250. doi: 10.1037/0278-6133.13.3.238.
    1. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–473. doi: 10.1037/0278-6133.25.4.462.
    1. Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193–203. doi: 10.1007/s11904-008-0028-y.
    1. Rivet AK. A situated-information motivation behavioral skills model of care initiation and maintenance (sIMB-CIM): an IMB model based approach to understanding and intervening in engagement in care for chronic medical conditions. J Health Psychol. 2011;16(7):1071–1081. doi: 10.1177/1359105311398727.
    1. Paintsil E, Kyriakides TC, Antwi S, Renner L, Nichols JS, Amissah K, et al. Clinic-based pediatric disclosure intervention trial improves pediatric HIV status disclosure in Ghana. J Acquir Immune Defic Syndr. 2020;84(1):122–131. doi: 10.1097/QAI.0000000000002316.
    1. Beck AT, Steer SR, Brown GK. Beck depression inventory: Texas psychological corporation. Harcourt Brace & Co: New York; 1996.
    1. Broadbent E, Ellis CJ, Thomas J, Gamble G, Petrie KJ. Can an illness perception intervention reduce illness anxiety in spouses of myocardial infarction patients? A randomized controlled trial. J Psychosom Res. 2009;67(1):11–15. doi: 10.1016/j.jpsychores.2008.11.006.
    1. Cutrona CE, Russell DW. The provisions of social relationships and adaptations to stress. Adv Personal Relationships. 1987;1:37–67.
    1. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–529. doi: 10.1002/nur.10011.
    1. Carey MP, Schroder KE. Development and psychometric evaluation of the brief HIV knowledge questionnaire. AIDS Educ Prev. 2002;14:172–182. doi: 10.1521/aeap.14.2.172.23902.
    1. Kagotho N, Patak-Pietrafesa M, Ssewamala FM, Kirkbride G. Assessing the association between depression and Savings for Kenyan Youth Using a validated child depression inventory measure. J Adolesc Health. 2018;62(1S):S21–S28. doi: 10.1016/j.jadohealth.2017.11.002.
    1. Kagee A, Nel A, Saal W. Factor structure of the Beck depression inventory-II among south Africans receiving antiretroviral therapy. AIDS Care. 2014;26(2):257–262. doi: 10.1080/09540121.2013.802278.
    1. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. Hoboken, NJ: Wiley; 2004.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Vreeman RC, Nyandiko WM, Marete I, Mwangi A, McAteer CI, Keter A, et al. Evaluating a patient-centred intervention to increase disclosure and promote resilience for children living with HIV in Kenya. AIDS. 2019;33(Suppl 1):S93–S101. doi: 10.1097/QAD.0000000000002183.
    1. Lentoor AG. Psychosocial challenges associated with caregiving in the context of pediatric HIV in rural eastern cape. Front Public Health. 2017;5:127. doi: 10.3389/fpubh.2017.00127.
    1. Lentoor AG, Asante KO, Govender K, Petersen I. Psychological functioning among vertically infected HIV-positive children and their primary caregivers. AIDS Care. 2016;28(6):771–777. doi: 10.1080/09540121.2015.1124979.
    1. Lv Y, Zhao Q, Li X, Stanton B, Fang X, Lin X, et al. Depression symptoms among caregivers of children in HIV-affected families in rural China. AIDS Care. 2010;22(6):669–676. doi: 10.1080/09540120903334633.
    1. Ofori-Atta A, Reynolds NR, Antwi S, Renner L, Nichols JS, Lartey M, et al. Prevalence and correlates of depression among caregivers of children living with HIV in Ghana: findings from the Sankofa pediatric disclosure study. AIDS Care. 2018;25:1–10.
    1. Kikuchi K, Poudel KC, Rwibasira JM, Majyambere A, Mutabazi V, Nyonsenga SP, et al. Caring for perinatally HIV-infected children: call for mental care for the children and the caregivers. AIDS Care. 2017;29(10):1280–1286. doi: 10.1080/09540121.2017.1307917.
    1. American Academy of Pediatrics Committee on pediatrics AIDS Disclosure of illness status to children and adolescents with HIV infection. Pediatrics. 1999;103(1):164–166. doi: 10.1542/peds.103.1.164.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel